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Differential mechanisms of action 
of the trace amines octopamine, 
synephrine and tyramine on the 
porcine coronary and mesenteric 
artery
Andy Hsien Wei Koh  1, Russ Chess-Williams1,2 & Anna Elizabeth Lohning1
Trace amines such as p-tyramine, p-octopamine and p-synephrine are found in low concentrations 
in animals and plants. Consumption of pre-workout supplements containing these plant-derived 
amines has been associated with cardiovascular side effects. The aim of this study was to determine 
the mechanisms of action of these trace amines on porcine isolated coronary and mesenteric arteries. 
Noradrenaline caused contraction of mesenteric arteries and relaxation of coronary arteries. In 
both tissues, all three trace amines induced contractions with similar potencies and responses were 
unaffected by the β-adrenoceptor antagonist propranolol (1 µM), the nitric oxide synthase inhibitor 
L-NNA (100 µM), or the TAAR-1 antagonist, EPPTB (100 nM). However, the contractile responses of 
mesenteric arteries, but not coronary arteries, were significantly reduced by depletion of endogenous 
noradrenaline. Mesenteric responses to all three amines were abolished in the presence of prazosin 
(1 µM) whereas residual contractile responses remained in the coronary artery which were inhibited 
by a high concentration (100 µM) of EPPTB. The results suggest complex responses of the coronary 
artery to the trace amines, with activity at α1-adrenoceptors and potentially TAARs other than 
TAAR-1. In contrast the actions of the amines on the mesenteric artery appeared to involve indirect 
sympathomimetic actions and direct actions on α1-adrenoceptors.
p-Tyramine (tyramine), p-octopamine (octopamine) and p-synephrine (synephrine) are substituted phenethyl-
amines with a phenolic hydroxyl group in the para-position (Fig. 1). They are found in nanomolar concentrations 
in the mammalian nervous system and have thus been described as “trace amines”1. They also occur naturally in 
citrus plants such as Citrus aurantium2. Since 2004, Citrus aurantium extracts have been marketed as ergogenic 
and weight-loss aids, but there are limited studies to support this claim3. The safety of Citrus aurantium-listed 
supplements is still debated as adverse cardiovascular effects have been associated with their use4.
A number of actions of these trace amines on cardiovascular tissues has been reported. In some vascular 
tissues, tyramine has been shown to act as an indirectly acting sympathomimetic agent, promoting the release 
of endogenous noradrenaline5. Moreover, tyramine and octopamine cause nitric oxide dependant vasodilatory 
responses in pre-contracted rat mesenteric vascular beds6. Synephrine and octopamine are weak direct agonist 
effects at the α1-adrenoceptors of the isolated rat aorta7–9. In addition, octopamine and synephrine have been 
shown to exert weak direct β1-adrenoceptor agonist effects on isolated cardiac tissues and to activate cloned 
β2-adrenoceptors10,11. Thus, the amines can potentially exert cardiovascular effects via both direct or indirect 
mechanisms, but the extent of these actions in different vessels of the same species has not been explored.
Recently it has been recognised that these amines may exhibit some activity mediated via trace 
amine-associated receptors (TAARs)12,13. Six subtypes of this receptor have been identified, but knowledge of their 
distribution and functions is limited. All three amines have been shown to activate human TAAR-1 expressed in 
cloned cells and increase cAMP levels, with tyramine being the most potent drug12–14. It has been hypothesised 
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that tyramine and octopamine acts directly on TAARs to cause vasoconstriction in endothelium-denuded rat 
aortas15,16 and pig coronary arteries17, but no selective antagonists were available to investigate this hypothesis. 
The presence of specific tyramine receptors had previously been proposed to explain rat aortic responses to syn-
ephrine that were resistant to conventional receptor antagonists8. Thus, there is some indirect evidence to suggest 
that tyramine and synephrine may induce some vascular responses via specific receptors.
The aim of the present study was to investigate the actions and mechanisms of action of the trace amines on 
the mesenteric and coronary artery using a porcine model. The mesenteric artery is densely innervated by the 
sympathetic nerves, and is a major regulator of blood flow to the gastrointestinal system during physiological 
stress18. Blood flow to the intestine can be drastically reduced (>80%) during exercise which results in the shunt-
ing of blood to the skeletal and cardiac muscle19. In contrast, during physiological stress the adrenergic nervous 
system ensures an increased blood flow to cardiac muscle via the coronary circulation20,21. Thus, in this study, the 
relative potencies of the trace amines tyramine, octopamine and synephrine were investigated on the vascular 
tone of mesenteric artery and the coronary artery and the mechanisms of action for each amine in the two func-
tionally very different arteries determined. The role of TAAR-1 in responses was also examined using EPPTB 
(RO-5212773), a recently developed selective antagonist for TAAR-122.
Results
Responses of the porcine mesenteric artery. All three trace amines produced concentration-depend-
ent contractions of the porcine arterial rings (Fig. 2). Tyramine and synephrine produced similar maximum 
responses, whilst those to octopamine were significantly greater (unpaired Welch’s t-test, p < 0.05). All three trace 
amines had similar potencies that were not significantly different (pEC50 ranging from 3.25–3.91). The endog-
enous amine, noradrenaline produced greater contractions than the three trace amines and was also the most 
potent drug tested (Fig. 2, Table 1).
Responses of the porcine coronary artery. All three trace amines produced concentration-dependent 
contractions of porcine coronary arterial rings (Fig. 3). Octopamine and synephrine produced similar maximum 
responses, whilst those to tyramine were greater, the difference between tyramine and octopamine being statis-
tically significant (p < 0.05). The potencies of all three amines were similar and ranged from 3.30–3.88 (Table 2). 
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Figure 1. Chemical structures of the trace amines (tyramine, octopamine, and synephrine) and noradrenaline.
Figure 2. Initial cumulative-dose responses of trace amines and noradrenaline on isolated mesenteric artery. 
The amines shown are tyramine (● n = 6), synephrine (■, n = 6) and octopamine (▲, n = 6). The data are 
presented as percent of contraction to 60 mM potassium chloride (%KCl). Welch corrected unpaired t-test,  
*, p < 0.05 vs. tyramine; ^, p < 0.05 vs. synephrine.
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The endogenous amine noradrenaline failed to produce contraction and only relaxations were observed (Fig. 3). 
These relaxations were converted to contractions in the presence of the β-adrenoceptor antagonist propranolol 
(1 µM). The maximum contractile responses to noradrenaline (33.4 ± 2.7% of the response to potassium) were 
significantly greater than those to octopamine (20.3 ± 4.6%, p < 0.05) and synephrine (21.1 ± 7.3%, p < 0.05), 
but not tyramine (32.3 ± 4.5%). In the presence of both propranolol (1 µM) and the α1-adrenoceptor antagonist 
prazosin (1 µM) responses to noradrenaline were abolished completely.
The role of endogenous noradrenaline release in responses in mesenteric artery. In mes-
enteric arteries, tyramine pre-treatment for 30 minutes nearly abolished subsequent responses to tyramine 
with a > 90% reduction in maximal contraction and a rightward shift of curves (pEC50 value 2.87 ± 0.06, 
n = 6; Student’s t-test p < 0.05) (Fig. 4). In tissues depleted of endogenous noradrenaline, the maximal con-
tractions to synephrine were reduced by 58% and maximal responses to octopamine were halved. However, 
the 30-minute tyramine pre-treatment did not affect the potencies (pEC50 values) of either synephrine or 
octopamine (Fig. 4). The contractile responses to exogenous noradrenaline were not significantly affected by 
tyramine pre-treatment (Table 1).
To examine whether responses to any of the trace amines involved the release of nitric oxide, tissues were 
incubated with the nitric oxide synthase inhibitor, L-NNA (100 µM). None of the responses to the trace amines 
was affected by the removal of nitric oxide (Table 1).
The role of endogenous noradrenaline release in responses in coronary artery. Tyramine 
pre-treatment did not affect the potencies or maximal contractions to either tyramine itself or synephrine (Fig. 4, 
Table 2). Noradrenaline depletion did appear to reduce responses to octopamine by about 50%, but the change 
was not statistically significant (Fig. 4). None of the responses to the amines was affected by the removal of nitric 
oxide with L-NNA (Table 2).
Role of direct adrenoceptor stimulation in trace amine-induced vasoconstriction in mesenteric 
artery. In noradrenaline-depleted mesenteric artery rings the presence of the α1-adrenoceptor antagonist pra-
zosin (1 µM) abolished the responses to all three trace amines (Fig. 5, Table 1). Prazosin caused a rightward shift 
of concentration-response curves to noradrenaline (P < 0.05) without affecting maximum responses (Table 1). 
Neither maximum contractile responses nor potencies for any of the trace amines or noradrenaline were changed 
in the presence of propranolol (1 µM) (Table 1).
Role of direct adrenoceptor stimulation in trace amine-induced vasoconstriction in coronary 
artery. In noradrenaline-depleted coronary artery rings the presence of prazosin (1 µM) reduced maximum 
contractions produced by tyramine, octopamine and synephrine by about half without significantly affecting 
agonist potency (Fig. 5, Table 2). Contractile responses to synephrine were the most significantly affected by pra-
zosin, but responses were again not completely abolished. Neither maximum contractile responses nor potencies 
for any of the amines changed significantly in the presence of propranolol (1 µM) (Table 2).
Trace amine and interventions
Controls Treatment
Sample number (n)Max contraction (%KCl) Potency (pEC50) Max contraction (%KCl) Potency (pEC50)
Tyramine
Tyramine pre-treatment (3 mM) 30.0 ± 3.9 3.91 ± 0.14 2.9 ± 0.7* 2.87 ± 0.06* 6
Propranolol (1 µM) 2.9 ± 0.7 2.49 ± 0.19 2.9 ± 0.6 2.88 ± 0.27 6
Prazosin (1 µM) 2.9 ± 0.7 2.49 ± 0.19 Abolished* Abolished* 6
L-NNA (100 µM) 4.2 ± 2.7 2.50 ± 0.23 6.5 ± 3.0 2.81 ± 0.56 4
Synephrine
Tyramine pre-treatment (3 mM) 25.6 ± 4.8 3.81 ± 0.12 10.9 ± 2.6* 3.76 ± 0.26 6
Propranolol (1 µM) 12.5 ± 2.9 3.90 ± 0.51 16.1 ± 3.8 3.45 ± 0.41 6
Prazosin (1 µM) 9.6 ± 2.6 3.81 ± 0.56 Abolished* Abolished* 5
L-NNA (100 µM) 19.2 ± 10.1 4.06 ± 0.68 17.4 ± 9.8 2.29 ± 1.19 4
Octopamine
Tyramine pre-treatment (3 mM) 63.4 ± 6.3 3.25 ± 0.12 19.9 ± 2.3* 3.60 ± 0.21 5
Propranolol (1 µM) 17.1 ± 3.6 3.80 ± 0.44 15.4 ± 4.4 3.46 ± 0.52 5
Prazosin (1 µM) 14.0 ± 2.8 3.80 ± 0.45 Abolished* Abolished* 6
L-NNA (100 µM) 16.7 ± 9.3 3.80 ± 0.44 12.8 ± 6.0 3.55 ± 0.41 6
Noradrenaline
Tyramine pre-treatment (3 mM) 85.7 ± 12.2 5.42 ± 0.21 85.9 ± 6.5 5.22 ± 0.13 5
Propranolol (1 µM) 81.9 ± 5.9 5.92 ± 0.14 91.4 ± 4.4 5.65 ± 0.09 5
Prazosin (1 µM) 87.7 ± 4.7 5.92 ± 0.14 81.9 ± 5.2 5.10 ± 0.08* 5
Table 1. Effects of antagonists on the maximum responses and potency values of p-synephrine, octopamine, 
tyramine, noradrenaline and phenylephrine in porcine mesenteric arteries. Paired Student’s t-test *p < 0.05 vs 
control.
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Role of Trace amine-associated receptor 1 (TAAR-1) in trace amine-induced vasoconstriction 
of coronary artery. In noradrenaline-depleted tissues,the possible involvement of the TAAR-1 receptor in 
mediating responses was investigated using the selective TAAR-1 antagonist EPPTB (Fig. 6, Table 2). The effects 
of this antagonist were dependent on the concentration of the antagonist. At the lower concentration (100 nM), 
EPPTB did not reduce responses to any of the trace amines, and for tyramine, responses were greater in the pres-
ence of this antagonist, although the change was not statistically significant.
The higher concentration of EPPTB (100 µM) did not affect pEC50 values for any of the amines but reduced 
maximum responses to both tyramine and synephrine by 70%, whilst responses to octopamine were reduced by 
53% (Fig. 6, Table 2).
Trace amine and interventions
Controls Treatment
Sample number (n)Max contraction (%KCl) Potency (pEC50) Max contraction (%KCl) Potency (pEC50)
Tyramine
Tyramine pre-treatment (3 mM) 32.3 ± 4.5 3.30 ± 0.13 34.12 ± 6.5 3.37 ± 0.12 8
Propranolol (1 µM) 24.1 ± 3.8 3.27 ± 0.12 22.3 ± 2.9 3.23 ± 0.11 5
Prazosin (1 µM) 39.3 ± 7.5 3.51 ± 0.17 24.3 ± 5.9** 3.26 ± 0.21 6
EPPTB (100 nM) 22.8 ± 7.5 3.03 ± 0.31 31.4 ± 6.7 2.94 ± 0.14 6
EPPTB (100 µM) 13.4 ± 2.1 3.13 ± 0.09 4.0 ± 1.1** 3.10 ± 0.18 7
L-NNA (100 µM) 34.6 ± 4.5 3.42 ± 0.20 41.6 ± 4.1 3.27 ± 0.14 6
Octopamine
Tyramine pre-treatment (3 mM) 20.3 ± 4.6 4.04 ± 0.43 13.7 ± 3.9 3.58 ± 0.29 6
Propranolol (1 µM) 12.6 ± 4.5 3.85 ± 0.68 20.7 ± 6.3 3.35 ± 0.34 5
Prazosin (1 µM) 13.7 ± 3.9 3.55 ± 0.27 5.9 ± 2.6* 3.15 ± 0.24* 6
EPPTB (100 nM) 6.5 ± 2.0 3.31 ± 0.88 8.1 ± 2.9 2.94 ± 0.25 5
EPPTB (100 µM) 16.5 ± 2.9 3.43 ± 0.18 7.8 ± 2.5* 3.04 ± 0.20 6
L-NNA (100 µM) 18.8 ± 6.0 3.13 ± 0.49 17.6 ± 1.5 3.27 ± 0.13 5
Synephrine
Tyramine pre-treatment (3 mM) 21.1 ± 7.3 3.50 ± 0.26 13.1 ± 3.4 3.55 ± 0.19 6
Propranolol (1 µM) 10.5 ± 3.0 3.74 ± 0.44 16.9 ± 0.3 2.59 ± 0.29 7
Prazosin (1 µM) 22.5 ± 6.7 3.21 ± 0.80 6.0 ± 2.1* 3.70 ± 0.35 6
EPPTB (100 nM) 25.1 ± 7.2 3.42 ± 0.43 27.0 ± 5.1 3.54 ± 0.33 6
EPPTB (100 µM) 12.8 ± 4.3 3.82 ± 0.42 3.9 ± 1.3* 3.83 ± 0.36 8
L-NNA (100 µM) 34.4 ± 6.5 3.29 ± 0.28 24.8 ± 4.5 3.60 ± 0.31 6
Noradrenaline
Propranolol (1 µM) −16.9 ± 1.5 6.98 ± 0.48 33.4 ± 2.7** 5.40 ± 0.15* 6
Propranolol + Prazosin (1 µM) −16.9 ± 1.5 6.98 ± 0.48 4.0 ± 1.5** 5.29 ± 0.65* 6
Table 2. Effects of antagonists on the maximum responses and potency values of tyramine, octopamine, 
synephrine and noradrenaline in porcine coronary arteries. Paired parametric Student’s t-test *vs. controls 
p < 0.05. **vs. controls p < 0.01.
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Figure 3. (Left) Concentration-response curves of the porcine coronary artery to tyramine, octopamine and 
synephrine (n = 6–8). (Right) Concentration-response curves to noradrenaline in the absence of antagonists 
and in the presence of the β-adrenoceptor antagonist propranolol (1 M) and in the combined presence of 
propranolol (1 µM) and the α1-adrenoceptor antagonist prazosin (1 µM). Responses are expressed as a 
percentage of the contractile response to potassium chloride (60 mM). Student’s paired parametric t-test 
*p < 0.05 vs. the relaxation before addition of antagonists.
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Discussion
All three trace amines contracted the mesenteric artery but were weaker and less potent than the biogenic amine 
noradrenaline. The potency order for the amines was noradrenaline > tyramine = synephrine = octopamine 
where the differences between the three trace amines were not significantly different. Previously vasoconstrictor 
effects of tyramine on canine mesenteric arteries23,24 and octopamine on rat mesenteric arterioles25 have been 
observed, but the vascular effects of synephrine are unclear. Huang et al. (1995) reported that synephrine was 
incapable of producing contractions of isolated rat mesenteric arteries26, but in our study synephrine produced 
concentration-dependent vasoconstrictions of the porcine mesenteric artery, suggesting that species differences 
may occur. In the same study by Huang and colleagues, a Citrus aurantium extract caused dose-dependent 
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Figure 4. Concentration-response curves to tyramine (A,D), octopamine (B,E) and synephrine (C,F) in 
control tissues (○), mesenteric (A–C) and coronary arteries (D–F) previously depleted of neuronal NA (▪) 
using prolonged contact (60 mins) with a high concentration (3 mM) of tyramine. Data are means ± sem values 
from 6 to 24 experiments, expressed as a percentage of the contractile response to potassium chloride (60 mM). 
Student’s paired parametric t-test *p < 0.05 vs. control.
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Figure 5. Concentration-response curves to trace amines in the absence (○) and presence of prazosin 
(1 µM, ■) in NA-depleted mesenteric arteries (A–C); and NA-depleted coronary arterial rings (D–F). Data 
are means ± sem (n = 5–7) values expressed as a percentage of the contractile response to potassium chloride 
(60 mM). Student’s paired parametric t-test *p < 0.05 vs control.
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vasocontractions of the rat mesenteric artery with a maximum value of 27 ± 3% (% 60 mM KCl), a value similar 
to the maximum contractions observed in the responses to synephrine in this current study. In contrast to our 
experiments on isolated mesenteric arteries, Anwar and colleagues showed a vasodilatory response in perfused 
rat mesenteric beds6. The discrepancy between the reports may be a result of differences in perivascular nerve 
distribution, as there is a greater density in non-adrenergic non-cholinergic nerves 2nd and 3rd branches of mes-
enteric arteries27. Thus differences between the Anwar study and our study may be explained by differences in 
species (rat vs pig) of type of vessel examined (perfused vascular bed vs larger artery).
On the coronary artery, all three trace amines were partial agonists and contracted the tissues with potencies 
similar to those seen on the mesenteric artery (ie. pEC50 range 3.3–4.0). The observations for tyramine were 
consistent with previous studies on the porcine coronary artery17 and the rat aorta8,9,15. However, unlike the 
mesenteric artery, the left anterior coronary artery contains a high proportion of β2-adrenoceptors and relatively 
few α1-adrenoceptors28 and noradrenaline administered to control arteries caused vasorelaxation, which would 
be consistent with predominant β2-adrenoceptor activation. In the presence of the β-adrenoceptor antagonist, 
propranolol, the responses to noradrenaline were reversed to vasoconstriction. The constriction of the coronary 
smooth muscle in response to noradrenaline was caused by α1-adrenoceptors as evidenced by the abolition of 
responses in the presence of the α1-adrenoceptor antagonist prazosin. In contrast to noradrenaline, propranolol 
did not affect the responses to the trace amines, and even in the presence of prazosin, these amines could produce 
coronary artery vasoconstriction suggesting a non-adrenoceptor mechanism of action.
To further investigate the mechanisms involved in the vasoconstriction induced by the trace amines, the con-
tribution of indirect actions and direct adrenoceptor activity were examined. The inhibition of NO synthase did 
not significantly affect responses to any of the amines indicating they did not stimulate release of NO. However, 
depletion of sympathetic stores of noradrenaline did have an effect and has been shown to greatly reduce the 
responses of tissues to indirectly acting sympathomimetic drugs29,30. Tyramine was first described as an indi-
rectly acting sympathomimetic drug by Burn and Rand (1958), who showed that the depletion of endogenous 
noradrenaline stores, completely abolished the effects of tyramine but not directly acting amines31.
The mesenteric vasculature contains a dense neuronal network that would redirect blood flow away from the 
intestine during sympathetic nervous system activation18. The incubation of porcine mesenteric arteries with 
a high concentration (3 mM) of tyramine for 30 minutes almost abolished subsequent responses of tissues to 
tyramine, indicating that stores of noradrenaline were depleted. Responses to exogenous noradrenaline were 
not affected by prior depletion of noradrenaline stores, demonstrating direct activation of α-adrenoceptors by 
noradrenaline caused vasoconstriction. In contrast, the responses to octopamine and synephrine were halved 
in noradrenaline-depleted tissues, suggesting that, like tyramine, the release of endogenous noradrenaline from 
sympathetic nerves contributes, at least partially, to the responses of these mesenteric vessels to these trace amines.
Different results were obtained in the coronary arteries where the three trace amines continued to elicit sig-
nificant responses after incubations to deplete endogenous noradrenaline stores. Responses to tyramine were 
almost identical in control and noradrenaline-depletion tissues, however responses to octopamine and syneph-
rine appeared to be reduced slightly but the changes were small and not statistically significant. These results 
suggest that in the coronary artery, unlike the mesenteric artery, the release of endogenous noradrenaline from 
sympathetic nerves does not contribute significantly to the responses of coronary vessels to trace amines. This 
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Figure 6. Concentration-response curves to tyramine (A,D), octopamine (B,E) and synephrine (C,F) in the 
absence (○) and presence of the TAAR-1 antagonist, EPPTB at 100 nM (■;A–C) or 100 µM (▲;D–F) in porcine 
coronary arterial rings. Data are means ± sem from 5 to 8 separate experiments, expressed as a percentage of 
the contractile response to potassium chloride (60 mM). Student’s paired parametric t-test *p < 0.05 vs. control, 
**p < 0.01 vs. control.
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conclusion was further supported by the finding that the response of the coronary artery to noradrenaline in the 
absence of antagonists was relaxation, making it impossible for the release of endogenous noradrenaline to cause 
the contractile responses to the trace amines.
In mesenteric arteries the small contractile responses to the trace amines remaining after noradrenaline 
depletion were not affected by the β-adrenoceptor antagonist, propranolol, but were abolished in the presence 
of prazosin. This indicates that the amines lacked significant effects on vascular β-adrenoceptors in this tissue 
and that the residual contractile effects after noradrenaline depletion were mediated via α1-adrenoceptor stim-
ulation. It has previously been reported that responses of the coronary artery to the trace amines, tyramine and 
β-phenylethylamine (β-PEA) were not affected by either prazosin or propranolol17, suggesting a lack of adreno-
ceptor involvement in responses. However, the coronary responses to synephrine and octopamine were not 
explored. In the present study, the maximum contractions of coronary arteries to all three trace amines were 
significantly reduced by prazosin indicating a weak partial agonist action at the α1-adrenoceptors of this tis-
sue. These results are consistent with previous data using rat aorta where octopamine and synephrine activated 
α1-adrenoceptors to cause contraction7,9,15. However, the residual vasoconstrictions to these three amines in the 
presence of prazosin suggests the involvement of another non-adrenergic receptor. Other monoamines such as 
5-HT, histamine and dopamine are known to cause constriction of pig coronary arteries, but blockade of their 
respective receptors does not affect responses to tyramine or β-PEA17. This prompted the authors to propose that 
these amines were acting on TAARs although an antagonist was not available at the time to test this hypothesis.
The physiological effects of trace amine-associated receptors were first identified in the process of olfaction, 
but these receptors have since been identified in tissues throughout the body. The TAAR-1 subtype is unusual 
as it is not involved in olfaction but is involved in neuromodulation and is therefore a potential target for drug 
development in the treatment of psychiatric and neurodegenerative disorders32. Stimulation of TAAR-1 causes 
activation of the G-protein alpha subunit (Gs) and subsequent increase in cellular cAMP concentration12. The 
selective competitive antagonist for TAAR-1, EPPTB (RO-5212773) was first described by33. It has a high affinity 
for the mouse TAAR-1 (Ki = 0.9 nM) and was employed in the present study at a concentration of 100 nM. The 
maximum responses to tyramine, but not octopamine or synephrine, appeared to be increased in the presence 
of 100 nM EPPTB although the effect was not statistically significant. Had tyramine activated TAAR-1 receptors 
enhanced responses would be expected since the receptor normally inhibits contraction. This would fit with the 
known activation of adenylyl cyclase following activation of this receptor and the inhibition of contraction by 
intracellular cAMP. It has been reported that tyramine is more potent at TAAR-1 than octopamine or syneph-
rine13,14. However, the effects of EPPTB are known to be species-dependent33 since the drug exhibited a high affin-
ity for the mouse variant of TAAR-1 (Ki = 0.9 nM) but a much lower affinity for the rat (Ki = 942 nM) and human 
TAAR-1 (Ki > 5 µM). The affinity of EPPTB at the porcine receptor is unknown, but we examined a higher con-
centration of the antagonist that would block responses mediated via the low-affinity variant of this receptor. In 
the presence of the higher concentration of EPPTB (100 µM), contractile responses to all three trace amines were 
reduced by more than half. Whether this represents an action of these trace amines at the low affinity TAAR-1 or a 
non-selective action at other TAAR receptors at higher drug concentrations is not known. Unfortunately, further 
studies will have to wait until selective drugs at other TAAR subtypes have been developed.
Conclusion
This study has shown that the trace amines, (tyramine, octopamine and synephrine) can induce vasoconstriction 
by a variety of complex mechanisms including direct α-adrenoceptor activation, indirect actions via release of 
endogenous noradrenaline and actions at another receptor yet to be identified, with the mechanism depending 
on the blood vessel. On the mesenteric artery, the trace amines induced contractions via an indirect sympathom-
imetic action and also a direct α1-adrenoceptor agonist mechanism. In the coronary artery, the amines appeared 
to have almost no indirect sympathomimetic actions but do elicit contractions via weak direct agonist actions on 
α1-adrenoceptors and possibly an action on TAAR receptors other than the TAAR-1 subtype.
Methods and Materials
Tissue preparation. Hearts and gastrointestinal tracts from 5-month-old female pigs were obtained from 
the local abattoir and transported in ice-cold Krebs-bicarbonate solution to the laboratory. The left anterior 
descending coronary artery or the inferior mesenteric artery were isolated and 3 mm length rings were suspended 
between stainless-steel hooks and stationary supports in 8 mL organ bath (EZ-baths, Global Towns, CA) contain-
ing Krebs-bicarbonate solution (composition in mM: NaCl 118, NaHCO3 25, glucose 11.7, MgSO4 2.4, KH2PO4 
1.2, KCl 1.2, CaCl2 2.5) maintained at 37 °C and continuously oxygenated with 5% CO2 in oxygen. The rings were 
mounted under a resting tension of 5 g and the tension developed by the circular smooth muscle in response to 
the addition of drugs was measured using isometric force transducers coupled to a PowerLab computer system 
(AD Instruments, Castle Hill, Australia).
Experimental protocol. After equilibrating the tissues for 30 minutes, cumulative concentration-response 
curves to either noradrenaline, phenylephrine, tyramine, synephrine or octopamine were generated. After wash-
out, responses to the amines were repeated and responses to KCl (60 mM) were obtained at the end of the exper-
iment. Responses were expressed as a percentage of the response to 60 mM KCl.
To investigate the possible indirect sympathomimetic action of these amines; the tissues were incubated with 
a high concentration of tyramine (3 mM) for 30 minutes to deplete pre-synaptic noradrenaline (NA) stores. After 
washout, responses to noradrenaline, tyramine, synephrine or octopamine were again obtained.
To investigate the mechanisms involved in the functional actions of these amines; α1- or β-adrenoceptor 
antagonists (prazosin or propranolol respectively; both 1 µM), trace amine-associated receptor 1 antagonist 
(EPPTB; 100 nM and 100 µM) or the nitric oxide synthase inhibitor, L-Nω-Nitroarginine (L-NNA; 100 µM) were 
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added 30 minutes before the addition of agonists. Control experiments without the addition of the antagonist 
were also performed, but repeated curves to the amines were not significantly different and correction of the 
second test curve in the presence of the antagonist was not required.
Statistical analysis. Concentration-response curves were analysed using PRISM 8 (GraphPad Software, San 
Diego, USA). The data are represented as mean ± s.e. mean with n indicating the number of animals from which 
arterial rings were obtained. Comparison of the different concentration-response curves was performed using 
paired Student’s t-test when comparing 2 normally distributed groups (e.g. pEC50 in the absence v.s. presence of 
antagonists), or a Welch corrected unpaired Student’s t-test applied to the normalised responses which may have 
unequal variances. Statistical significance was demonstrated by a p-value of less than 0.05. Potency was expressed as 
the pEC50 value (-log EC50, which was the molar concentration producing a response 50% of the maximum effect).
Drug and chemicals. (+)Noradrenaline-bitartrate, (±)p-synephrine, (±)p-octopamine hydrochloride, 
(±)p-tyramine, (+)-phenylephrine hydrochloride, prazosin hydrochloride, propranolol hydrochloride, EPPTB 
(RO-5212773, N-(3-Ethoxyphenyl)-4-(1-pyrrolidinyl)-3-(trifluoromethyl)benzamide) and Nω- nitro-L-arginine 
(L-NNA) were obtained from Sigma-Aldrich (Sydney, Australia). All drugs except RO-5212773 were dissolved 
in distilled water and then diluted with Krebs-bicarbonate solution. RO-5212773 was dissolved in 1% dimethyl 
sulfoxide (DMSO) prior to dilution with Krebs-bicarbonate solution.
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